1.A Case of Urethral Diverticulum Combined with Giant Stone.
Yung Hwi LEE ; Chul Bo PARK ; Sung Soo AN ; Yang Il JANG ; Kyung Jun OH ; Kyu Hwan KIM
Korean Journal of Urology 1995;36(10):1165-1167
A case of one of the largest stone in a giant penile urethral diverticulum which disturbed voiding and ejaculation was responded with review of some literatures.
Diverticulum*
;
Ejaculation
;
Male
;
Urethra
2.The disorder of ejaculation in the treatment of the male infertility
Journal of Practical Medicine 2002;435(11):16-18
Ejaculatory incompentence is not able to ejaculate intravaginally. Psychological causes are generally associated with an inability to ejaculate intravaginally. The treatment of ejaculatory incompetence is very difficult and complicated. The treatment of retrograde ejaculation is much more difficult. Such patients have a very low volume ejaculate but numerous sperm can be found in the urine and on physical examination, testicles are of normal size. Sperm recovery from the urine could be used for AIH. The treatment for some men with paraplegia who do not ejaculate with a vibrator. We can perform the whole process of ejaculation in electro- ejaculation
Infertility
;
Ejaculation
;
Infertility, Male
3.Development and Validation of a Korean Version of the Premature Ejaculation Diagnostic Tool (PEDT).
Sung Chul KAM ; Deok Hyun HAN ; Jeong Ho HUH ; Sung Won LEE
Korean Journal of Andrology 2009;27(3):185-193
PROPOSE: Premature ejaculation (PE) is the most prevalent male ejaculation disorder. The premature ejaculation diagnostic tool (PEDT) was developed to systematically apply the DSM-IV-TR criteria in diagnostic PE. This study was designed to assess the validity of the Korean version of the PEDT as a diagnostic tool for PE. MATERIALS AND METHODS: The Korean version development of the PDET involved two stages: (1) Development of the initial language version through two independent forward translations and one backward translation. Discrepancies between the original English form and the first draft Korean translation were reviewed by the panel. Discrepancies between the original English form and the Korean translation were reviewed by the panel. (2) For psychometric validation and scoring system development, data was collected from men with and without PE based on clinician diagnosis, using DSM-IV-TR criteria. A total of 98 patients with a DSM-IV-TR defined PE and 100 men without PE were enrolled into the study and requested to complete the PEDT, which was translated into Korean. The PE patients were also requested to measure intravaginal ejaculatory latency time (IELT). The 50 men of no-PE group and all PE group were requested to come for a second visit to assess the PEDT's retest reliability. The results were analyzed statistically by SPSS version 12. RESULT: The mean age of the no-PE group and PE group were 43.4+/-9.2 and 51.6+/-9.0, respectively. The geometric mean IELT of the PE group was 115.37+/-78.14s. The number of men reporting IELTs of <1, 1-<2 and >2min were 28 (28.6%), 29 (29.6%) and 41 (41.8%), respectively. The Cronbach's alpha score of the Korean version of PEDT was calculated as 0.93, showing adequate internal consistency. The test-retest correlation coefficients of each item were higher than 0.72 and the correlation coefficients of the total score was 0.88. (P<0.001) Sensitivity and specificity analyses suggested a score of < or =8 indicated no-PE, 9 and 10 probable PE, and > or =11 PE. CONCLUSIONS: The Korean version of PEDT was highly effective in detecting the presence of PE. The result of our study supports its validity as a diagnostic instrument in the clinical setting.
Ejaculation
;
Humans
;
Male
;
Premature Ejaculation
;
Psychometrics
;
Sensitivity and Specificity
;
Translations
4.Effects of Glans Penis Augmentation Using Hyaluronic Acid Gel for Premature Ejaculation.
Tae Il KWAK ; Byung Gyu JEON ; Jae Hyun BAE ; Du Geon MOON ; Je Jong KIM
Korean Journal of Andrology 2003;21(2):76-79
PURPOSE: We evaluated the effect of injectable hyaluronic acid gel(HA) for augmentation of the glans penis and treatment of premature ejaculation. MATERIALS AND METHODS: In 139 patients with premature ejaculation, dorsal neurectomy(Group I; n=25) and glandular augmentation using HA(Group II; n=114) were done. Six months after each procedure, ejaculatory latency, penile vibratory threshold, and patient and partner satisfaction were assessed in both groups. RESULTS: There was no significant difference in preoperative ejaculation time in the two groups, being 89.2+/-40.3 sec in Group I and 96.5+/-52.3 sec in Group II. Postoperatively, ejaculatory latency was significantly increased, to 235.6+/-58.6 sec in Group I and 324.2+/-107.6 sec in Group II(p<0.01). The postoperative vibratory threshold was also significantly increased in both groups(p<0.01). Satisfaction was expressed by both the patient and his partner in 68%(17/25) and 44%(11/25), respectively, in Group I and 79.8%(91/114) and 64.0% (73/114) in Group II. The maximal glandular girth was significantly increased, from 9.2+/-0.6 cm to 11.0+/-0.4 cm, in Group II. CONCLUSIONS: Glandular augmentation with injectable HA gel appears to be very effective for the treatment of premature ejaculation. Glandular augmentation with a bulking agent is anticipated to replace the hazardous, irreversible dorsal neurectomy.
Ejaculation
;
Humans
;
Hyaluronic Acid*
;
Male
;
Penis*
;
Premature Ejaculation*
5.Meta-analysis with meta-regression and systematic review of the efficacy of on-demand tramadol for the treatment of lifelong premature ejaculation.
Philippine Journal of Surgical Specialties 2013;68(3):109-120
This is a systematic review and meta-analysis on the efficacy of ondemand tramadol for the treatment of lifelong premature ejaculation.
METHODS: A systematic review and meta-analysis with metaregression of trials evaluating the use of tramadol to treat premature ejaculation using intravaginal ejaculation latency time as a measure.Relevant studies were identified using PubMed, Ebscohost,MEDLINE, EMBASE and the Cochrane Collaboration Library.
RESULTS: This analysis included 8 publications. Study of the intravaginal ejaculation latency time (IELT) among 599 patients showed that tramadol was effective in subjects with premature ejaculation as seen by the significant difference in mean IELT of tramadol treated patients versus those receiving placebo (mean difference 2.43 minutes; 95% CI 0.93-3.93; P=0.002). The effect on IELT between tramadol and paroxetine was not statistically significant (mean difference -0.58; 95% CI -5.81 to 4.65; P=0.83).Meta-regression analysis showed that the lower the dose of tramadol,the higher its benefit in the prolongation of IELT, however, there was no significant difference (95% CI regression coefficient -0.0956 to 0.0322). There was a significant difference in adverse effects profile of tramadol versus placebo (risk ratio 2.48; 95% CI 1.55-3.98; overall effect Z= 3.79; P<0.0002) and overall therapeutic effectiveness between tramadol compared to placebo (risk ratio 0.55; 95% CI 0.46-0.67; P<0.00001).
CONCLUSION: On-demand tramadol is an effective treatment for lifelong premature ejaculation. It significantly prolongs the intravaginal ejaculation latency time. The overall adverse events and overall therapeutic effectiveness are significantly greater during treatment with tramadol.
Human ; Female ; Premature Ejaculation ; Ejaculation ; Tramadol ; Paroxetine ; Medline ; Pubmed
6.Effectiveness of a topical anesthetic mixture in the treatment of premature ejaculation
Bac Hoai Nguyen ; Quang Nguyen
Journal of Medical and Pharmaceutical Information 2005;0(12):31-35
Background: Premature ejaculation is one of the most common sexual dysfunction which affects the quality of life in both men and women. Objectives: To assess the effects of a topical anesthetic mixture in the treatment of Premature Ejaculation (PE). Subjects and method: Fifty-six men diagnosed as PE were guided to use a local anesthetic mixture of procaine-xylocain applied to glands on the penis before sexual activity (about 15 minutes prior), the course of treatment lasted 3 months. Results:There was a significant increase in the mean of intravaginal ejaculatory latency time (IEL n from 1.87 to 8.41 mins (p<0. OS) and satisfying scores of both overall sex life and sexual relationship with their partners. General results were divided into 4 degrees: good (30.2%) average (43.4%) no result (15.1%) and negative results (11.3%). Some side effects included retarded ejaculation or anejacualation (9.43%) decrease of glands penis and vagina sensitivity (28.3% and 9.43% respectively). Conclusion: While there is no effective therapy for PE, anesthetic creams might be effective for treatment of the disorder. \r\n', u'\r\n', u'
topical anesthetic mixture
;
premature ejaculation
7.Lifestyle Modification Strategy for Patients with Premature Ejaculation as Metabolic Syndrome
Yu Seob SHIN ; Hong Seok SHIN ; Jong Kwan PARK
The World Journal of Men's Health 2019;37(3):372-373
No abstract available.
Humans
;
Life Style
;
Premature Ejaculation
8.Premature ejaculation: an update on definition and pathophysiology.
Mohammed Abu EL-HAMD ; Ramadan SALEH ; Ahmad MAJZOUB
Asian Journal of Andrology 2019;21(5):425-432
Premature ejaculation (PE) is the most common male sexual dysfunction, which represents a diagnostic as well as a therapeutic challenge for physicians. However, no universally accepted definition is currently available for PE. As a result, physicians continue to diagnose patients with PE according to major guidelines set by the professional societies. These guidelines either recommend the use of validated questionnaires or patient-reported outcomes. Recent efforts directed toward classifying PE may help provide a better understanding of the prevalence and risk factors of this disorder. While the exact etiology of PE has not been clearly elucidated, several risk factors have been strongly reported in the literature. Clearly, to understand the revised definition of PE, its etiology and pathophysiology is necessary to improve the clinical management of this medical condition and form the basis of future research in this regard. In this review, we highlight the past and current definitions of PE and present an appraisal on the classifications and theories suggested for the etiopathogenesis of PE.
Humans
;
Male
;
Premature Ejaculation/physiopathology*
9.The Efficacy and Safety of Tamsulosin 0.2mg/day on Sexual Function in BPH: A Multicenter Open-label, Non-comparative, 3 Months Observational, Phase IV Prospective Study.
Du Geon MOON ; Young Dae BAE ; Sung Won LEE ; Ki Hak MOON ; Tae Young AHN ; Woo Sik JEONG ; Dae Yeol YANG ; Je Jong KIM
Korean Journal of Andrology 2009;27(2):123-129
PURPOSE: The aim of this study was to assess the efficacy and safety of tamsulosin, 0.2mg/day on sexual function in Korean BPH patients. Patients and Methods: 116 patients (mean age: 60 yrs) with BPH were enrolled in this study and 0.2mg of tamsulosin was administrated every night for 3 months. Primary efficacy was evaluated with changes of IIEF and GEQ. Secondary efficacy parameters were changes of IPSS and QoL, uroflowmetry, changes of total IIEF and IIEF domain score according to the severity of IPSS, and retrograde ejaculation. RESULTS: Before treatment, patients of moderate IPSS (8-19) and severe IPSS (20-35) were 56% and 44% and QoL<3 and QoL>3 were 33.6% and 66.4%. In primary efficacy evaluation, total IIEF score was significantly increased from 37.0+/- 18.2 to 40.5+/- 18.9 (p<0.01). All domains of IIEF except orgasmic function were significantly improved. GEQ showed improvement of erection in 34.4% and intercourse ability in 30.1%. In secondary efficacy evaluation, IPSS was significantly decreased from 18.4+/- 6.9 to 12.9+/- 6.7 (p<0.01) and QoL was significantly improved from 3.8+/- 1.1 to 2.7+/- 1.4 (p<0.01). Qmax significantly increased from 14.2+/- 8.3 to 16.5+/- 11.3 ml/sec (p<0.01). Total IIEF score and EF domain score were significantly improved from 36.8+/- 18.5 to 41.8+/- 19.1 (p<0.01) and from 13.0+/- 7.1 to 14.7+/- 7.9 (p<0.01) in patients of moderate IPSS but no improvement in severe patients. Retrograde ejaculation occurred in 2 patients (2%). No serious adverse reactions were observed. CONCLUSIONS: Tamsulosin, 0.2mg/day was effective and safe dose for the improvement of LUTS and sexual function for Korean BPH/LUTS patients.
Ejaculation
;
Humans
;
Male
;
Orgasm
;
Prospective Studies
;
Sulfonamides
10.Prevalence Of Premature Ejaculation And Erectile Dysfunction And Their Associated Factors Among Urban And Rural Population Of Malaysia
Mohd Rohaizat Hassan ; Mohd Fadhli Samsuri ; Shamsul Azhar Shah ; Nazarudin Safian ; Zulkifli Md Zainuddin ; Hasanain Faisal Ghazi
Malaysian Journal of Public Health Medicine 2017;17(3):86-96
The purpose of this study was to determine the prevalence and factors associated with of Premature Ejaculation &Erectile Dysfunctionamong Malaysian men.A cross-sectional study was conducted in urban and rural areas using standardized and validated self-administeredquestionnaires.A total of 319 samples were recruited for PE screening. The overall prevalence of PE was 31.7% with 20.7% and 40.8% for urban and rural arearespectively. Depression, anxiety and frequent masturbation were significantly associated with PE. While For ED, infrequent sexual intercourse was the sole factor significantly associated with ED.PE and ED were highly prevalent in both urban and rural areas; with several significant preventable associated factors.
Premature Ejaculation
;
Erectile Dysfunction
;
Sexual Dysfunction
;
Malaysia